T44.0X

Clinical Causes: Accidental ingestion or exposure to anticholinesterase medications, especially in children or individuals unfamiliar with the drugs. Incorrect dosage—either underdosing, leading to ineffective treatment, or overdosing, resulting in toxicity. Misuse or misuse due to misunderstanding of dosing instructions. Medication errors during prescribing, dispensing, or administration. Intentional overdose in cases of self-harm or suicidal attempts.

Key Symptoms: Increased salivation and sweating Nausea and vomiting Muscle weakness or twitching Difficulty breathing or respiratory distress Pinpoint pupils Abdominal cramping Diarrhea Bradycardia (slow heart rate) Confusion, dizziness, or weakness Fasciculations (muscle twitches) Seizures in severe cases

Diagnosis Path: Diagnosis is generally based on a combination of clinical evaluation and patient history. Physicians look for characteristic signs and symptoms associated with anticholinesterase poisoning. Laboratory tests, including blood and urine analysis, may help confirm exposure by detecting the presence of the medication or its metabolites. Additional assessments might include measuring cholinesterase activity in the blood, which can be decreased in poisoning cases, aiding in differentiating from other neurological disorders.

Treatment Protocols: Administration of atropine, an anticholinergic agent that helps counteract the effects of excessive cholinesterase inhibition. Use of pralidoxime (2-PAM) to reactivate cholinesterase enzymes, if administered early in poisoned patients. Supportive care such as oxygen therapy and mechanical ventilation if respiratory compromise occurs. Monitoring cardiac and respiratory functions closely. Gastrointestinal decontamination procedures like lavage or activated charcoal, if indicated and performed soon after ingestion. Treating seizures or other complications as needed.